|
    GSK U.S.: NYSE

    GSK PLC ADR

    Watchlist
    GSKUS
    After Hours
    Last Updated: May 26, 2023 7:40 p.m. EDT Delayed quote

    $ 34.35

    0.11 0.32%
    After Hours Volume: 12.67K
    Close Chg Chg %
    $34.24 0.13 0.38%
    Advanced Charting
    Volume: 2.21M 65 Day Avg: 2.89M
    76% vs Avg
    34.19 Day Range 34.53
    28.47 52 Week Range 45.51

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Create Account … or Log In
    Symbol
    Company
    Price
    Chg/Chg %
    (Go to Your Watchlist)
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Add Tickers
    No Saved Watchlists

    Create a list of the investments you want to track.

    Create Watchlist …or learn more
    Uh oh

    Something went wrong while loading Watchlist.

    Go to Watchlist

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    Overview

  • Overview
  • Profile
  • Charts
  • Financials
  • Historical Quotes
  • Analyst Estimates
  • Options
  • Premium Tools

    • GSK Overview

    Key Data

    • Open $34.29
    • Day Range 34.19 - 34.53
    • 52 Week Range 28.47 - 45.51
    • Market Cap $69.9B
    • Shares Outstanding 2.05B
    • Public Float 2.02B
    • Beta 0.53
    • Rev. per Employee $504.22K
    • P/E Ratio 4.18
    • EPS $8.19
    • Yield 5.84%
    • Dividend $0.35
    • Ex-Dividend Date May 18, 2023
    • Short Interest 3.72M 05/15/23
    • % of Float Shorted 0.18%
    • Average Volume 2.89M

    Performance

    5 Day
    • -3.85%
    1 Month
    • -4.97%
    3 Month
    • -0.95%
    YTD
    • -2.56%
    1 Year
    • -23.66%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 21 Full Ratings

    Recent News

    Read full story

    GSK rises Friday, still underperforms market

    May. 26, 2023 at 12:03 p.m. ET by MarketWatch Automation
    Read full story

    GSK falls Thursday, underperforms market

    May. 25, 2023 at 12:03 p.m. ET by MarketWatch Automation
    Read full story

    GSK outperforms market despite losses on the day

    May. 24, 2023 at 12:03 p.m. ET by MarketWatch Automation
    Read full story

    GSK rises Tuesday, outperforms market

    May. 23, 2023 at 12:03 p.m. ET by MarketWatch Automation

    GSK Sells Haleon Shares at 335p Each, Raising GBP804M

    May. 12, 2023 at 2:17 a.m. ET

    GSK to Sell Its 2.5% Stake in Haleon

    May. 11, 2023 at 11:55 a.m. ET
    Read full story

    IPOs Kenvue Stock Jumps in IPO of Former J&J Consumer-Health Business

    May. 4, 2023 at 1:20 p.m. ET by Barron's
    Read full story

    FDA approves GSK RSV vaccine

    May. 3, 2023 at 1:56 p.m. ET by Eleanor Laise

    GSK's RSV Vaccine Approved for Older Adults by FDA

    May. 3, 2023 at 1:13 p.m. ET
    Read full story

    Biotech and Pharma GSK Earnings Beat Expectations, Updates on Pipeline

    Apr. 26, 2023 at 9:32 a.m. ET by Barron's

    GSK's 1Q Results Beat Expectations -- Earnings Review

    Apr. 26, 2023 at 9:00 a.m. ET
    Read full story

    GSK first quarter profit dips to £1.49 billion but beat analyst forecasts

    Apr. 26, 2023 at 3:21 a.m. ET

    GSK's 1Q Sales, Net Income Expected Lower With Outlook in Focus -- Earnings Preview

    Apr. 25, 2023 at 7:06 a.m. ET

    Haleon PLC 1Q Trading Has Been Strong

    Apr. 20, 2023 at 2:37 a.m. ET

    ADRs End Mostly Higher; Natura & Co., Bellus Health Trade Actively

    Apr. 18, 2023 at 6:39 p.m. ET

    Toronto Stocks Edge Higher; Bellus Health Surges on GSK Buyout

    Apr. 18, 2023 at 12:06 p.m. ET

    Bellus Health Toronto-Listed Shares Double on GSK Takeover

    Apr. 18, 2023 at 10:12 a.m. ET

    Bellus Health Shares Soar Premarket on Takeover by GSK >BLU

    Apr. 18, 2023 at 5:54 a.m. ET
    Read full story

    GSK reports positive phase 3 data for UTI oral antibiotic

    Apr. 17, 2023 at 2:58 a.m. ET

    ADRs End Higher, Adaptimmune Therapeutics and Alibaba Trade Actively

    Apr. 11, 2023 at 6:03 p.m. ET

    10 Health Care Stocks With Whale Alerts In Today's Session

    May. 25, 2023 at 1:35 p.m. ET on Benzinga.com

    Peering Into GSK's Recent Short Interest

    May. 19, 2023 at 4:01 p.m. ET on Benzinga.com

    WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake

    May. 19, 2023 at 10:51 a.m. ET on Benzinga.com

    Pfizer's (PFE) RSV Vaccine for Infants Gets FDA Panel Vote

    May. 19, 2023 at 10:46 a.m. ET on Zacks.com

    Could Latecomer Moderna Match Big Pharma Rivals in RSV?

    May. 16, 2023 at 2:00 p.m. ET on Motley Fool

    A Bitter Pill to Swallow: Teva's $235M Challenge to GSK Dismissed by Supreme Court

    May. 15, 2023 at 1:31 p.m. ET on Benzinga.com

    3 Personalized Medicine Stocks to Buy for Long-Time Returns

    May. 15, 2023 at 7:50 a.m. ET on InvestorPlace.com

    GSK's Meningitis Vaccine Candidate: Crushing Clinical Trials or Just Playing Catch-up with Bexsero and Menveo?

    May. 12, 2023 at 1:08 p.m. ET on Benzinga.com

    Tesla's Huge Recall In China, Twitter's New CEO, Amazon Space Satellites Expected To Launch This Summer: Today's Top Stories

    May. 12, 2023 at 10:24 a.m. ET on Benzinga.com

    Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody

    May. 12, 2023 at 9:53 a.m. ET on Benzinga.com

    GSK Trims Stake On Consumer Business Spin Off, Raises £804M

    May. 12, 2023 at 9:47 a.m. ET on Benzinga.com

    The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer

    May. 11, 2023 at 10:23 a.m. ET on Motley Fool

    Biotech ETFs Pop on M&A Resurgence

    May. 10, 2023 at 12:33 p.m. ET on Zacks.com

    WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns

    May. 8, 2023 at 7:14 a.m. ET on Benzinga.com

    J&J's Kenvue: Unlocking Value in a Stagnant Market

    J&J's Kenvue: Unlocking Value in a Stagnant Market

    May. 4, 2023 at 7:13 p.m. ET on GuruFocus.com

    Ionis (IONS) Q1 Earnings Surpass Estimates, Sales Match

    May. 4, 2023 at 8:58 a.m. ET on Zacks.com

    A Shot of Success: GSK's Arexvy Wins FDA Approval, Pioneering RSV Prevention for Older Adults in Multi-Billion Dollar Market

    May. 3, 2023 at 3:38 p.m. ET on Benzinga.com

    KVUE Stock: Should You Buy Into the Kenvue IPO?

    May. 3, 2023 at 11:00 a.m. ET on InvestorPlace.com

    Pharma Giant Pfizer To Start Selling Haleon Stake Within Months, CFO Says

    May. 3, 2023 at 8:51 a.m. ET on Benzinga.com

    Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?

    May. 3, 2023 at 6:20 a.m. ET on Zacks.com

    GSK PLC ADR

    GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations, Research and Development, and Consumer Healthcare. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

    Competitors

    Name Chg % Market Cap
    AstraZeneca PLC ADR 1.02% $225.23B
    Sanofi ADR -0.15% $133.43B
    Pfizer Inc. -0.61% $212.26B
    Dynavax Technologies Corp. 1.08% $1.44B
    Novartis AG ADR 0.08% $194.09B
    Teva Pharmaceutical Industries Ltd. ADR 1.64% $8.48B
    Innoviva Inc. 0.08% $860.73M
    Merck & Co. Inc. -1.10% $281.83B